Age | Gender | Kidney diseases | Pulmonary complications | Other comorbidities | Pathogen | Site/clinical manifestation | Treatment (start timing if described) | Dosage of antifungals | Outcome | Reference |
---|---|---|---|---|---|---|---|---|---|---|
66 | Male | ESKD from FSGS | Past NTM disease | None | Aspergillus spp. | Lung, intracranial abscess | Described in the manuscript | Described in the manuscript | Discharge (day 380) and death one month later | This case |
15 | Male | CAPD, cause unknown (global sclerosis) | Not described | Not described | Aspergillus spp. | Intracranial hemorrhagic abscesses | L-AMB | Not described | Death (day 13) | [28] |
55 | Female | ESKD starting PD, cause reflux nephropathy | A smoker of 20 cigarettes per day | Not described | Aspergillus fumigatus | Lung | L-AMB (from day 3) | Not described | Death (day 3) | [29] |
34 | Male | HD | Past pulmonary tuberculosis | Type 1 DM | Not described | Lung (in a tuberculous cavity), laryngeal tissue mass | VRCZ | 6 mg/kg every12 hours | Death (Two days later) | [15] |
54 | Female | HD | Not described | Type 2 DM | Not described | Rhino-sinusitis | The antifungals with surgical drainage | Not described | Unknown | [15] |
49 | Male | HD | Not described | long‐standing hypertension | Not described | submandibular swelling and lung | Caspofungin, oral VRCZ | Not described | Stable | [30] |